Robyn M. Malone Mba

Robyn M. Malone, MBA, CMR, currently serves as Director of Strategic Development & Advocacy at ANI Pharmaceuticals, Inc., with a progression of roles including Associate Director positions in Strategic Development & Advocacy and National Thought Leader Liaison for Rare Disease, starting in January 2022. Prior to this, Robyn M. Malone worked at Genzyme from 2012 to 2022 as Executive Area Business Manager for Neurology, successfully launching multiple sclerosis treatments while achieving national recognition for sales performance. Earlier experience includes roles at Biogen Idec and Wyeth Pharmaceuticals, where Robyn M. Malone managed business development in neurology and psychiatry, achieving significant market share and formulary status. Robyn M. Malone holds a BBA in International Business/Economics from Saint Mary's College and an MBA in International Marketing from Loyola University Chicago.